H.Res. 1631 — Introduced in House

IV 119th CONGRESS 2d Session H. RES. 1631 IN THE HOUSE OF REPRESENTATIVES October 19, 2026Mrs. Foushee submitted the following resolution; which was referred to the Committee on Energy and Commerce RESOLUTION Expressing support for the designation of the third week of October as National Hunter Syndrome Awareness Week. Whereas Hunter syndrome, also known as Mucopolysaccharidosis Type II (MPS II), is a rare genetic disorder affecting approximately 1 in 100,000 to 170,000 live male births worldwide; Whereas Hunter syndrome is caused by a deficiency of the enzyme iduronate-2-sulfatase, resulting in the harmful accumulation of complex sugars in the body’s cells and leading to progressive damage to organs and systems, including the brain; Whereas symptoms often appear in early childhood and may include developmental delays, physical impairments, and a significantly shortened lifespan; Whereas early diagnosis and intervention are critical to improving quality of life and outcomes for individuals affected by Hunter syndrome; Whereas increased public and medical awareness can lead to earlier diagnoses, better treatment options, and expanded research efforts toward potential therapies and a cure; and Whereas families affected by Hunter syndrome face extraordinary emotional, financial, and medical challenges, and deserve greater support, understanding, and advocacy: Now, therefore, be it That the House of Representatives— (1) supports the designation of National Hunter Syndrome Awareness Week; (2) encourages Federal agencies, research institutions, and advocacy organizations to expand efforts in education, research, and the development of treatments for Hunter syndrome; and (3) urges continued congressional support for funding rare disease research and initiatives that directly benefit individuals and families in the Hunter syndrome community.